Karin Thron, MD
Hospice and Palliative Medicine · Santa Fe, NMNPI 1164528428
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Eisai Inc. accounts for 72.0% of it on its own, with 4 other manufacturers making up the rest.
Across 12 payments — averaging $23.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$200
- GE HealthCare$21
- Novo Nordisk$20
- Otsuka America Pharmaceutical, Inc.$18
- Exact Sciences$18
What the payments were for
- Food & beverage$277100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 8 | $200 |
| GE HealthCare | 1 | $21 |
| Novo Nordisk | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Exact Sciences | 1 | $18 |
How this compares
Too few hospice and palliative medicine providers in New Mexicoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 31 | $25,686 |
| ValacyclovirValacyclovir Hcl | 21 | $2,432 |
| Levothyroxine Sodium | 149 | $1,539 |
| Gabapentin | 92 | $1,192 |
| Estradiol | 27 | $1,155 |
| Duloxetine Hcl | 40 | $1,002 |
| Bupropion XlBupropion Hcl | 29 | $921 |
| SynthroidLevothyroxine Sodium | 26 | $918 |
| Rosuvastatin Calcium | 63 | $847 |
| Lisinopril | 102 | $686 |
| Trazodone Hcl | 102 | $658 |
| Atorvastatin Calcium | 67 | $647 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $620 |
| Omeprazole | 58 | $606 |
| Amlodipine Besylate | 87 | $597 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Santa Fe
- Bridget FahyAlbuquerque$465
- Christopher HawkAlbuquerque$177
- Kayla CarusoAlbuquerque$125
- Anju ManralAlbuquerque$111
- Kathleen MaleyAlbuquerque$90
- Julianne DeanAlbuquerque$22
- Allison CookAlbuquerque$17
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.